Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma (GlioCave/NOA17)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02715297 |
Recruitment Status :
Recruiting
First Posted : March 22, 2016
Last Update Posted : March 10, 2020
|
Sponsor:
Technische Universität München
Collaborator:
Helmholtz Zentrum München
Information provided by (Responsible Party):
Technische Universität München
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | February 2023 |
Estimated Study Completion Date : | February 2023 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):